TCL Archive NCI Expects 200 CCP applications; Grand Rapids Workshop To Offer Last Chance to Ask Questions September 24, 1982
TCL Archive Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease December 28, 2012